Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Titan Pharmaceuticals Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 22 | 25 | +3 |
| Shares | 949.8K | 978.1K | +28.3K (+3.0%) |
| Value | $787.4K | $632.7K | −$154.7K (−19.6%) |
New holders (4)
Institutions that held Titan Pharmaceuticals Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 29,675 | $19.2K | 0.00% |
| St Germain D J Co Inc | 1 | $1 | 0.00% |
| Nemes Rush Group LLC | 1 | $1 | 0.00% |
| Acadian Asset Management LLC | 1 | $0 | 0.00% |
Sold out (1)
Institutions that held Titan Pharmaceuticals Inc at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| UBS Group AG | 1,526 | $1.27K |